News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
617,157 Results
Type
Article (47320)
Company Profile (226)
Press Release (569611)
Section
Business (172849)
Career Advice (1727)
Deals (30761)
Drug Delivery (99)
Drug Development (72372)
Employer Resources (134)
FDA (15617)
Job Trends (14076)
News (298963)
Policy (30200)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (7)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2679)
Academic (1)
Accelerated approval (3)
Adcomms (18)
Allergies (79)
Alliances (43165)
ALS (74)
Alzheimer's disease (1257)
Antibody-drug conjugate (ADC) (103)
Approvals (15611)
Artificial intelligence (221)
Autoimmune disease (13)
Automation (14)
Bankruptcy (274)
Best Places to Work (11457)
BIOSECURE Act (10)
Biosimilars (81)
Biotechnology (166)
Bladder cancer (55)
Brain cancer (25)
Breast cancer (232)
Cancer (1773)
Cardiovascular disease (138)
Career advice (1449)
Career pathing (25)
CAR-T (128)
Cell therapy (366)
Cervical cancer (15)
Clinical research (58562)
Collaboration (686)
Compensation (354)
Complete response letters (17)
COVID-19 (2465)
CRISPR (37)
C-suite (180)
Cystic fibrosis (95)
Data (1693)
Decentralized trials (2)
Denatured (24)
Depression (36)
Diabetes (220)
Diagnostics (5981)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (34)
Drug discovery (102)
Drug pricing (107)
Drug shortages (29)
Duchenne muscular dystrophy (61)
Earnings (67645)
Editorial (29)
Employer branding (18)
Employer resources (118)
Events (94567)
Executive appointments (590)
FDA (16591)
Featured Employer (45)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (600)
Gene editing (92)
Generative AI (21)
Gene therapy (258)
GLP-1 (662)
Government (4491)
Grass and pollen (4)
Guidances (45)
Healthcare (19066)
Huntington's disease (20)
IgA nephropathy (20)
Immunology and inflammation (82)
Indications (24)
Infectious disease (2578)
Inflammatory bowel disease (133)
Inflation Reduction Act (7)
Influenza (41)
Intellectual property (68)
Interviews (275)
IPO (14699)
IRA (45)
Job creations (3110)
Job search strategy (1271)
Kidney cancer (10)
Labor market (20)
Layoffs (362)
Leadership (12)
Legal (6583)
Liver cancer (68)
Lung cancer (261)
Lymphoma (118)
Machine learning (2)
Management (42)
Manufacturing (222)
MASH (50)
Medical device (13941)
Medtech (13945)
Mergers & acquisitions (16488)
Metabolic disorders (566)
Multiple sclerosis (56)
NASH (17)
Neurodegenerative disease (71)
Neuropsychiatric disorders (18)
Neuroscience (1669)
NextGen: Class of 2025 (6393)
Non-profit (4386)
Northern California (2158)
Now hiring (22)
Obesity (311)
Opinion (205)
Ovarian cancer (54)
Pain (74)
Pancreatic cancer (68)
Parkinson's disease (111)
Partnered (17)
Patents (166)
Patient recruitment (80)
Peanut (46)
People (51418)
Pharmaceutical (49)
Pharmacy benefit managers (17)
Phase I (17900)
Phase II (25722)
Phase III (19770)
Pipeline (767)
Podcasts (63)
Policy (101)
Postmarket research (2353)
Preclinical (7367)
Press Release (55)
Prostate cancer (82)
Psychedelics (29)
Radiopharmaceuticals (251)
Rare diseases (326)
Real estate (4852)
Recruiting (54)
Regulatory (20912)
Reports (31)
Research institute (2372)
Resumes & cover letters (260)
Rett syndrome (2)
RNA editing (1)
RSV (34)
Schizophrenia (60)
Series A (108)
Series B (66)
Service/supplier (5)
Sickle cell disease (50)
Southern California (1748)
Special edition (17)
Sponsored (27)
Startups (3267)
State (1)
Stomach cancer (12)
Supply chain (54)
The Weekly (38)
United States (18685)
Vaccines (587)
Venture capitalists (28)
Webinars (8)
Weight loss (222)
Women's health (29)
Worklife (11)
Date
Today (163)
Last 7 days (742)
Last 30 days (2903)
Last 365 days (33369)
2025 (5592)
2024 (34176)
2023 (38815)
2022 (49630)
2021 (53738)
2020 (51984)
2019 (45390)
2018 (34223)
2017 (30334)
2016 (29104)
2015 (33855)
2014 (25527)
2013 (21192)
2012 (22823)
2011 (23369)
2010 (22064)
Location
Africa (734)
Alabama (40)
Alaska (5)
Arizona (172)
Arkansas (13)
Asia (37102)
Australia (6456)
California (4789)
Canada (1641)
China (400)
Colorado (239)
Connecticut (249)
Delaware (107)
Europe (83036)
Florida (703)
Georgia (161)
Hawaii (1)
Idaho (52)
Illinois (448)
India (19)
Indiana (277)
Iowa (5)
Japan (123)
Kansas (83)
Kentucky (23)
Louisiana (9)
Maine (44)
Maryland (786)
Massachusetts (3768)
Michigan (157)
Minnesota (336)
Mississippi (2)
Missouri (71)
Montana (31)
Nebraska (22)
Nevada (50)
New Hampshire (66)
New Jersey (1390)
New Mexico (27)
New York (1343)
North Carolina (926)
North Dakota (8)
Northern California (2158)
Ohio (161)
Oklahoma (13)
Oregon (34)
Pennsylvania (1059)
Puerto Rico (7)
Rhode Island (21)
South America (1037)
South Carolina (14)
South Dakota (1)
Southern California (1748)
Tennessee (79)
Texas (703)
Utah (156)
Virginia (108)
Washington D.C. (55)
Washington State (462)
West Virginia (3)
Wisconsin (46)
617,157 Results for "nu med plus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment
January 24, 2025
·
4 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
BioMidwest
Nu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC Regions
Nu-Tek BioSciences is an innovative manufacturer of critical raw materials used in cell culture media for the development and manufacturing of pharmaceuticals.
June 4, 2024
·
3 min read
Press Releases
NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields
January 7, 2025
·
5 min read
Press Releases
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
November 4, 2024
·
7 min read
Press Releases
EssilorLuxottica acquires the Canadian med-tech start-up Cellview
February 11, 2025
·
1 min read
Press Releases
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy
November 6, 2024
·
3 min read
BioMidwest
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
VolitionRx Limited has announced that its Nu.Q® Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech, a leading veterinary diagnostics company.
April 23, 2024
·
6 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
BioMidwest
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
VolitionRx Limited has agreed a supply agreement with Fujifilm Vet Systems Co. Ltd, a leading veterinary diagnostic laboratory service, to launch the Nu.Q® Vet Cancer Test to veterinarians in Japan.
March 20, 2024
·
6 min read
1 of 61,716
Next
